Recently, Adrian V. Lee of University of Pittsburgh prepared a study for the U.S. Army Medical Research and Materiel Command regarding 3D printed medical models and breast cancer research. His findings are outlined in ‘A 3D Bioprinted Model for the Study of Premalignant Disease,’ published by the Defense Technical Information Center.
In hypothesizing that in vitro 3D bioprinted models of premalignant breast cells could help identify markers for low-risk premalignant disease, the research team was comprised of the following specialists as ultimately, they endeavored to 3D print mammary glands:
- Surgical oncologist
- Mammary gland biologist
- Biomedical engineer
- Cancer biologist
Goals were designated for each year of the study, and completed as follows:
- Year 1 – Quantify mammary gland development and find strain dependent differences.
- Year 2 – Keep characterizing development of the mammary glands.
- Year 3 – Study growth patterns of breast cells in vitro.
Mice were used extensively in the study too, with their ages corresponding to the onset of human puberty, and mammary glands not yet affected by estrus. With breeding pairs, the researchers were able to use mammary tissue for 3D imaging that could then be sent to University of Pittsburgh for 3D printing.
“This work represented the first 3D comparison of ductal architecture and patterning in inbred mouse strains of different genetic backgrounds,” states Lee. “The hypothesis for the study was that ductal patterning, and the implementation of stereotypical branching behaviors during early post-natal development differs with genetic background.”
The research team noted differences in:
- Total duct length
- Average duct length
- Total branch count
- Branch density
- Ductal segment diameter
As work progressed, the researchers began bioprinting directly with collagen Type 1 and additional ECM protein hydrogels:
“The mammary duct model we developed represents a world-first level of complexity generated using a bioprinter with multiple ECM and hydrogel components.”
In the next phase, the researchers used progenitor cells to 3D print the mammary ductal structure. Beyond that, they completed further imaging and assessing of the 3D progenitor cell (still ongoing).
Challenges occurred as they noticed a loss of structure in the models as cells began to affect the collagen detrimentally. All the bioprinted structures experienced delamination, no matter what types of cellular foundation they possessed. Growth was interrupted and characterization overall ‘inhibited.’ They redesigned the structure for better growth and quality in their research overall.
This new system, printed entirely in collagen type I, was fabricated with an inner diameter of 1.4 mm, matching the average breast. The team has now 3D printed over 25 of the bioprinted models successfully.
“In year 1 we encountered minor difficulties such as reduced fecundity in some mouse strains, but we continued these studies in year 2 and complete the mammary ductal development studies as noted above. During year 2, we had to change the design of the 3D ductal microenvironment, as the method we developed at the end of year 1 showed uneven plating of cells and delamination of collagen,” concluded the researchers. “We re-engineered the 3D ductal environment to allow perfusion and easier plating of cells. Preliminary results show that this model has better cell plating and cell survive when toxins are removed by perfusion. In year 3 (NCE) we will now study growth of cells in this microenvironment.”
3D printed medical models have made significant impacts in the past few years especially as more scientific facilities and hospitals have begun building labs onsite. From using them as guides to rebuild areas as complex as an eye socket to training medical students and even bioprinting brain tumors to learn more, models, surgical guides, implants, and devices, and changing the face of medicine today—and the lives of patients around the globe. Find out more about how 3D printed models may help in the study of breast cancer here. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: A 3D Bioprinted Model for the Study of Premalignant Disease]
You May Also Like
3D Printing Market Outlook 2021: Powder Bed Fusion and Multi Jet Fusion, Part 2
This is the second part of a Market Outlook for 2021 for both the Powder Bed Fusion and Multi Jet Fusion technologies. The first part can be found here. The...
How 3D Scanning Helps the Fire Brigade: Customization of a Rosenbauer Firetruck with EinScan Pro HD
Rosenbauer is the world’s leading manufacturer of systems for firefighting and disaster protection. The company develops and produces vehicles, fire extinguishing systems, equipment and digital solutions for professional, industrial, plant...
3D Printing Market Outlook 2021: Desktop Vat Polymerization (SLA, DLP)
Vat polymerization (SLA, DLP) has unexpectedly become a hot spot over the past year due to the effects of material companies and new startups entering the market. In this series,...
Powder Handling Station from Sinterit: The First Complete SLS Solution Ever
Sinterit has just launched its Powder Handling Station (PHS), a supporting device designed to make post-processing and powder recovery as clean as possible. It is also a clear call for...
View our broad assortment of in house and third party products.